$ULBI

WHITMORE BRADFORD T purchased $202K of ULBI (indirect holdings)

WHITMORE BRADFORD T purchased 32,876 indirectly-held shares of ULTRALIFE CORP (ULBI) at $6.13 ($0.20M total) on 2026-05-21.

Original reporting
SEC EDGAR · WHITMORE BRADFORD T
Published May 26, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ULBI
Bullish
medium confidence
Mentioned
$ULBI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

This provides a sentiment/positioning datapoint (insider increased holdings) but does not introduce new financial results, contracts, litigation, or product/regulatory milestones.

02

Market read

Traders may treat the disclosure as a small positive signal, but it should not be weighted like earnings or deal news.

03

What to watch

No 10b5-1 plan is cited, but the transaction is indirect and the article lacks context on prior buying/selling cadence or size versus typical insider activity.

Relevance 7/10Timing: Immediate (new Form 4 disclosure filed 2026-05-26; trade signal may be short-lived).

Background

The article is an SEC Form 4 insider transaction disclosure for ULTRALIFE CORP (ULBI).

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

ULTRALIFE director/10% owner Whitmore Bradford T bought 32,876 shares for ~$201.7K on 2026-05-21 via an open-market purchase.

Expected impact

Near-term impact likely limited; any move may fade unless followed by earnings/operational news.

Evidence & confidence

The filing is a Form 4 insider transaction with no stated 10b5-1 plan, but the article provides no new business developments or guidance changes.

Market effects

Minimal; this is company-specific insider buying with no sector-wide policy/product/regulatory trigger.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine portfolio rebalancing or driven by liquidity/compensation needs rather than a forward-looking view.

Key entities

  • ULTRALIFE CORP

    Subject of the Form 4 insider open-market purchase disclosed on 2026-05-26.

  • WHITMORE BRADFORD T

    Director and 10% owner who purchased 32,876 shares for ~$201.7K on 2026-05-21.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENSHighAI 9/10

EnerSys to Acquire Ultralife for $16 Per Share in Cash

EnerSys (ENS) agreed to acquire Ultralife for $16 per share in cash. The deal, subject to regulatory approvals, includes support from shareholders holding 40.3% of Ultralife's shares. The tender offer is expected to start within 10 business days and may close by April 27, 2027, with possible extensions.

$ENSHighAI 9/10

EnerSys to acquire Ultralife for $320 million in cash

EnerSys (ENS) agreed to acquire Ultralife (ULBI) for $320 million in cash, including debt. Ultralife shareholders will receive $16.00 per share, a 166% premium over Monday's closing price. The deal, approved by both boards, is expected to close in Q1 2027. EnerSys will finance the acquisition with available cash. Both companies' CEOs cited strategic benefits and value creation.

$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

$ULBIMed

Ultralife Corporation Reports Second Quarter Results

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil